VASCUL-AID Developing Trustworthy Artificial Intelligence (ai)-driven Tools to Predict Vascular Disease Risk and Progression
- Coordinator
- Stichting Amsterdam Umc, Netherlands
- Runs
- 1 May 2023 to 30 April 2029
- Status
- Running
- EU funding
- €6.0m
- Total cost
- €6.0m
- Partners
- 21 organisations in 10 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101080947
What the project is doing
In the project's own words, from its summary on CORDIS.
The aim of VASCUL-AID is to predict the risk of cardiovascular events and progression of the vascular diseases Abdominal Aortic Aneurysm (AAA) and Peripheral Arterial Disease (PAD) to influence the course of disease improving the patient’s quality of life and care and assisting clinicians to make better-informed decisions involving the patient. VASCUL-AID will allow us for the first time to identify patients who are at high risk for AAA growth or PAD progression and cardiovascular events.
To this end, we will deliver a clinically relevant and cost-effective trustworthy AI-driven platform (VASCUL-AID) that integrates multi-source parameters including imaging, proteomic and genomic data as well as life-style patient data from wearables to enable personalised vascular disease management. To maximise the personalised prevention strategies, VASCUL-AID leverages visualisation tools to improve clinician-patient communication and empower the patient.
The VASCUL-AID platform consists of AI risk-prediction tools, a patient communication app an a clinical dashboard to support clinical decision-making. A particular emphasis is placed on ethics, to ensure beneficial implementation of AI prediction tools. In this project, we aim to (1) build an EU-wide data infrastructure, (2) develop an AI-based progression prediction tools for AAA and PAD, (3) develop criteria according to the COMET initiative to assess the effectiveness of VASCUL-AID, and (4) clinically test and show proof-of-concept for the VASCUL-AID platform.
Once validated, this platform can be extended to other cardiovascular diseases (CVDs) as well. VASCUL-AID brings together 19 leading international organisations consisting of clinical academic centres, research institutes, universities and SMEs as well as large industry, patients organisations and policy makers that cover the full value chain to enable integration of the platform into clinical practice.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Stichting Amsterdam Umc | Amsterdam | Netherlands | Coordinator |
| Brightfish Be | Tervuren | Belgium | Participant |
| Asklepios Kliniken Hamburg GmbH | Hamburg | Germany | Associatedpartner |
| Asklepios Kliniken Hamburg GmbH | Hamburg | Germany | Participant |
| Medizinische Hochschule Brandenburg Campus GmbH | Neuruppin | Germany | Participant |
| Rwth Aachen Campus GmbH | Aachen | Germany | Associatedpartner |
| Hus-Yhtyma | Helsinki | Finland | Participant |
| Centre Hospitalier Universitaire De Nice | Nice | France | Participant |
| Azienda Unita' Sanitaria Locale Toscana Centro | Firenze | Italy | Associatedpartner |
| Stichting Allai Nederland | Amsterdam | Netherlands | Participant |
| Universiteit Twente | Enschede | Netherlands | Participant |
| Universitetet I Bergen | Bergen | Norway | Participant |
| Unidade Local De Saude De Sao Joao, E.p.e. | Porto | Portugal | Third party |
| Universidade De Aveiro | Aveiro | Portugal | Third party |
| Universidade Do Porto | Porto | Portugal | Participant |
| Faculty of Medicine, University of Belgrade | Belgrade | Serbia | Participant |
| Institut Za Nuklearne Nauke Vinca Institut Od Nacionalnog Znacaja Za Republiku Srbiju, Univerzitet U Begradu | Vinca Beograd | Serbia | Participant |
| Guys and St Thomas' Nhs Foundationtrust | London | United Kingdom | Associatedpartner |
| King's College London | London | United Kingdom | Associatedpartner |
| Oxford University Hospitals Nhs Foundation Trust | Headington | United Kingdom | Associatedpartner |
| The Chancellor, Masters and Scholars of the University of Oxford | Oxford | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI